Summary of Purpose
This study investigates the clinical practices, safety and effectiveness of Cerebrolysin in routine treatment of patients with moderate to severe neurological deficits after acute ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 4 April 2018.
|15 Apr 2018||22 Mar 2018||31 Mar 2020||31 Mar 2020||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|